Latest News

STAT Plus: Pharmalittle: Democratic drug pricing bill may be unconstitutional; FTC staff OKs Roche deal to buy Spark

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, we are happy to say, is rather modest. We look forward to hanging with a short person or two, catching up on our reading, puttering around the castle, and playing a few favorite melodies. And what about you? This remains a fine time to enjoy the great outdoors. You could make time for someone special. Or perhaps this is an opportunity to purchase a costume for a spooky day that is just around the corner. Feel free to write us for suggestions. Well, whatever you do, have a grand time. Enjoy, but be safe. And see you soon …

A report by the Congressional Research Services indicates the drug pricing bill pushed by House Democrats could run afoul of not one, not two, but three separate parts of the U.S. Constitution, STAT reports. At least one Republican has already seized on this new report — at another committee meeting this week, he held it up as a reason to slow down consideration of H.R. 3. The legislation is likely headed for a floor vote next month. The bad news for Democrats is that the potential constitutional issues with the bill can’t be fixed with a few tweaks.

Continue to STAT Plus to read the full story…

Source link

Related posts

Washington Monitors Coronavirus Patient’s Contacts


Israeli government dips into digital health with $33M grant


AACR Annual Meeting 2019 Highlighted Latest Advances in Cancer Research


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy